Usana Health Sciences Inc
USNA- Exchange
- NYSE
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0000896264
No open-market purchases or sales by Usana Health Sciences Inc insiders were filed in the last 90 days; 137 institutions reported holding it in 13F filings for Q2 2026, worth $261.1M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +4 vs. previous quarter
- 137
- 13F valueReported value at the end of Q2 2026
- $261.1M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding USNA, Q2 2026
No superinvestor reported holding USNA at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Usana Health Sciences Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 18, 2026 (view filing) | Jun 16 | 2 days | Neidig BrentCHIEF COMMERCIAL OFFICER | SSale | −5.00K | $19.45 | −$97.3K | −100.0%0 after | |
| Jun 16, 2026 (view filing) | Jun 12-15 | 4 days | Neidig BrentCHIEF COMMERCIAL OFFICER | SSale | −2.51K | $20.10 | −$50.5K | −33.4%5.00K after | 2 lots |
| Jun 8, 2026 (view filing) | Jun 8 | Same day | Jones Paul A.CHIEF PEOPLE OFFICER | SSale | −5.56K | $18.50 | −$102.9K | −100.0%0 after | |
| Jun 1, 2026 (view filing) | Jun 1 | Same day | Fleming John TurmanDirector | SSale | −2.45K | $17.93 | −$43.9K | −36.7%4.23K after | |
| May 29, 2026 (view filing) | May 28 | 1 day | Jones Paul A.CHIEF PEOPLE OFFICER | SSale | −6.81K | $18.95 | −$129.1K | −55.1%5.56K after | |
| May 28, 2026 (view filing) | May 27 | 1 day | Iiekking G DougCHIEF FINANCIAL OFFICER | SSale | −5.36K | $18.75 | −$100.5K | −100.0%0 after | |
| May 26, 2026 (view filing) | May 22 | 4 days | Fuller Gilbert ADirector | SSale | −1.06K | $18.66 | −$19.7K | −100.0%0 after | |
| May 8, 2026 (view filing) | May 7 | 1 day | Foukas JoshuaCHIEF LEGAL OFFICER | SSale | −3.79K | $19.82 | −$75.1K | −100.0%0 after | |
| Mar 20, 2026 (view filing) | Mar 20 | Same day | Fuller Gilbert ADirector | SSale | −1.06K | $17.00 | −$18.0K | −100.0%0 after | |
| Mar 3, 2026 (view filing) | Mar 3 | Same day | Benedict PeterCHIEF INFORMATION OFFICER | SSale | −4.55K | $19.38 | −$88.2K | −100.0%0 after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Usana Health Sciences Inc at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 1,620,148 | $34.6M | 1.05% | +810,074+100.0% | Added |
| BlackRock, Inc. | 1,554,189 | $33.2M | 0.00% | +363,773+30.6% | Added |
| Pzena Investment Management LLC | 1,205,587 | $25.7M | 0.08% | +96,654+8.7% | Added |
| Renaissance Technologies LLC | 958,520 | $20.5M | 0.03% | −59,110−5.8% | Reduced |
| Dimensional Fund Advisors LP | 837,426 | $17.9M | 0.00% | +3,203+0.4% | Added |
| Vanguard Capital Management LLC | 487,370 | $10.4M | 0.00% | +8,327+1.7% | Added |
| Creative Planning | 417,971 | $8.92M | 0.01% | +224,823+116.4% | Added |
| AQR Capital Management LLC | 408,086 | $8.71M | 0.00% | +111,666+37.7% | Added |
| Vanguard Portfolio Management LLC | 363,377 | $7.76M | 0.00% | +25,103+7.4% | Added |
| Geode Capital Management, LLC | 283,165 | $6.05M | 0.00% | +18,731+7.1% | Added |